Pleural Effusion
Conditions
Brief summary
The main objective of the study is to assess the cost-effectiveness ratio of two management strategies of pleurisy in adults : a strategy by systematic thoracic ultrasound versus a strategy without thoracic ultrasound.
Detailed description
Comparison of two management strategies pleural effusions from diagnosis and during the first year of follow up care. Patients are randomized into two groups, each group receiving a different management strategy. Both strategies are compared: Strategy A that involves the systematic use of thoracic ultrasound for the treatment of pleural effusion, treatment and follow up care. It will be possible to have recourse to other tests (such as chest CT) if deemed necessary by the practitioner. Strategy B, which consists of the usual care pleurisy and thus without use of ultrasound: gestures are guided either by chest radiograph or by CT chest as necessary in the treatment and monitoring. A systematic radiographic pleural after each gesture is performed. The management is inspired by the English recommendations currently validated and applied in Anglo-Saxon countries.
Interventions
PROCEDUREStrategy with thoracic ultrasound
This strategy involves the systematic use of thoracic ultrasound for the treatment of pleural effusion, treatment and follow up care.
Sponsors
University Hospital, Toulouse
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients hospitalized or seen in consultation with pleural effusion diagnosed clinically or radiologically whatever be its initial management.
Exclusion criteria
* Patient with a neoplasia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The cost-effectiveness ration | 1 year | Cost estimates will be conducted from the perspective of health insurance. The expenses incurred in the care of patients with pleurisy will be counted in both groups during the follow-up year. The effectiveness will be assessed against the complications of strategy (pneumothorax, respiratory sequelae, surgery, mortality, chest pain sequelae, radiological consequences). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The duration of hospitalization | 1 year | number of day of hospitalization between the two strategies |
Other
| Measure | Time frame | Description |
|---|---|---|
| The irradiation rate | 1 year | calculation of irradiation rate between the two strategies |
| Number of consultations | 1 year | The number of consultations between the two strategies |
Countries
France
Contacts
Primary ContactElise NOEL-SAVINA, MD
Backup ContactAlain DIDIER, Professor
Outcome results
None listed